Results 181 to 190 of about 1,913,070 (304)
Minimal residual disease (MRD)–guided ibrutinib and venetoclax (IVen) achieved durable remissions and high undetectable MRD (uMRD) rates in patients with high‐risk chronic lymphocytic leukaemia (CLL). Compared with historical ibrutinib monotherapy, IVen was associated with improved progression‐free and overall survival despite presence of complex ...
Maria Kislova +15 more
wiley +1 more source
Correction to "Studying Chronic Lymphocytic Leukemia Microenvironment in the Multi Omics Era". [PDF]
europepmc +1 more source
Optimal Chemotherapy Scheduling for Chronic Lymphocytic Leukemia Under Immune and Allergy Constraints. [PDF]
Abdullah R, Halanay A, Abou Orm L.
europepmc +1 more source
Summary To re‐evaluate chronic lymphocytic leukaemia (CLL) epidemiology in the era of modern therapy, data were extracted from the English National Cancer Registration Dataset (NCRD). A total of 34 427 consecutive diagnoses of CLL were recorded (2014–2022), the largest European dataset on record.
Temitope Erinfolami +18 more
wiley +1 more source
Correction to "EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation". [PDF]
europepmc +1 more source
Atypical Cutaneous Manifestation Leading to the Diagnosis of Chronic Lymphocytic Leukemia. [PDF]
Memon M.
europepmc +1 more source
Summary Microbial metabolites are key regulators of host immunity, yet their functional impact in chronic lymphocytic leukaemia (CLL) remains unclear. Following up on our earlier observations of microbiome dysbiosis in CLL, we performed predictive metabolic profiling based on 16S ribosomal RNA (rRNA) sequencing of oral and stool samples collected from ...
Monika Szelest +15 more
wiley +1 more source
The place of acalabrutinib-obinutuzumab combination in the first-line treatment of patients with chronic lymphocytic leukemia. [PDF]
Szymczyk A, Hus I.
europepmc +1 more source
Summary Haematological malignancies are rare in primary care and are hard to predict. Existing prediction models often require a specific working diagnosis and are based on extensive clinical information, access to which may be limited at initial work‐up in primary care.
Mathilde Egelund Christensen +9 more
wiley +1 more source

